All News #Library
Rare Diseases
Aardvark Voluntary Pauses HERO Trial in Prader-Willi Syndrome
27 Feb 2026 //
GLOBENEWSWIRE
Aardvark Submits FDA & IRB-Approved Trial Protocol FOR ARD-101
10 Feb 2026 //
GLOBENEWSWIRE
Aardvark Therapeutics Grants Inducements Under Nasdaq Listing
18 Jul 2025 //
GLOBENEWSWIRE
Aardvark Announces Receipt of Pediatric Disease Designation for Prader-Willi Syndrome
03 Aug 2023 //
PR NEWSWIRE
Aardvark Announces FDA Orphan Drug Designation Granted to ARD-101
20 Jun 2023 //
PR NEWSWIRE

Market Place
Sourcing Support